Liraglutide reduces myocardial metalloproteinase 2 activity without attenuating doxorubicin-induced cardiac dysfunction in rats

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Coronary disease and cardiovascular toxicity in patients with cancer Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology